Skip to main content
. 2018 Oct 18;8:15458. doi: 10.1038/s41598-018-33453-4

Figure 5.

Figure 5

The anti-tumor effect of LSN3213128 dosed orally in mice are shown using the following models: (A) NCI-H460 at 10 (red), 30 (green) and 60 (blue) mg/kg BIDx13, (C) A9 at 100 (red) mg/kg BIDx12 and (E) MDA-MB-231met2 at 30 (red) and 60 (green) mg/kg BIDx22. Vehicle is in black. A * next to the % T/C indicates a p-value < 0.05 compared to vehicle control. The ZMP (purple), AICAR (blue), SAICAR (green), dUMP (red), ATP (dark green),  AMP (aqua), GTP (brown), GMP (orange) & ZTP (plum) metabolite levels following LSN3213128 for the treatment groups above are shown for B) NCI-H460, D) A9 and F) MDA-MB-231met2. A * above the bar indicates a p-value < 0.05 using mean comparisons to vehicle control, Dunnett’s method using JMP 12.1.0.